Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(4 sites)
South Korea
Korea University Anam Hospital, Seoul Seoul National University Hospital, Seoul Severance Hospital, Seoul Samsung Medical Center, Seoul